BioCopy AG and Immatics enter into a collaboration to characterize T cell receptor - peptide-HLA interactions

Wednesday, July 7, 2021 1 min read

Key Takeaway: BioCopy AG and Immatics enter into a collaboration to characterize T cell receptor - peptide-HLA interactions

Full Press Release Details

BioCopy AG and Immatics enter into a collaboration to characterize T cell receptor - peptide-HLA interactions.